ANDRX (ADRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANDRX (ADRX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: PAUL ROBERT ST. ONGE who wrote (2)	9/18/1996 2:40:00 AM
From: rkrw	of 127

Is not ISIS in antisense and AndRx into drug delivery? I really dont see any similarities. Isis is a biotech, AndRx reformulates existing drugs, mainly as a super generic type of firm. AndRx does look like a solid co. If you compare them to Biovail, another drug delivery firm, it is clearly priced far more realistically with similar prospects going forward. Biovail's at about a $billion cap, AndRx closer to $200 million. AndRx also has an interesting JV with Sepracor to form a once daily version of Allegra, the antihistimine. I look for more JVs between the two companies in the future.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next